Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.640
+0.130 (8.61%)
At close: Jun 26, 2026, 4:00 PM EDT
1.600
-0.040 (-2.44%)
After-hours: Jun 26, 2026, 7:12 PM EDT
Neumora Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Neumora Therapeutics stock have an average target of 6.86, with a low estimate of 3.00 and a high estimate of 14. The average target predicts an increase of 318.29% from the current stock price of 1.64.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Neumora Therapeutics stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $6 → $4 | Buy | Maintains | $6 → $4 | +143.90% | Jun 18, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $18 → $7 | Buy | Reiterates | $18 → $7 | +326.83% | Jun 16, 2026 |
| Needham | Needham | Buy Reiterates $8 → $5 | Buy | Reiterates | $8 → $5 | +204.88% | Jun 15, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 15, 2026 |
| J.P. Morgan | J.P. Morgan | Sell Maintains n/a | Sell | Maintains | n/a | n/a | May 27, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
3.56M
EPS This Year
-0.92
from -1.45
EPS Next Year
-0.77
from -0.92
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 20.0M | |
| Avg | n/a | 3.6M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 3,437.1% |
| Avg | - | 1,269.5% |
| Low | - | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.67 | -0.39 | |
| Avg | -0.92 | -0.77 | |
| Low | -1.29 | -1.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.